Safety and efficacy of topical, fixed‐dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial

BACKGROUND: Psoriasis is a disease that commonly manifests in adolescence. Up to half of adults with psoriasis develop it before the age of 20. Topical formulations containing corticosteroids and/or vitamin D3 analogs are recommended for treatment. OBJECTIVE: This phase II study aimed to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichenfield, L.F., Marcoux, D., Kurvits, M., Liljedahl, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Pediatric Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318187/
https://www.ncbi.nlm.nih.gov/pubmed/31721327
http://dx.doi.org/10.1111/jdv.16077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318187/
https://www.ncbi.nlm.nih.gov/pubmed/31721327
http://dx.doi.org/10.1111/jdv.16077

Ejemplares similares